Clinical Trial: Swiss Primary Sclerosing Cholangitis Cohort Study

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational [Patient Registry]

Official Title: Swiss Primary Sclerosing Cholangitis Cohort Study

Brief Summary: The investigators wish to collect high quality prospective data on a rare disease in order to elucidate epidemiology, natural history, response to treatment and outcome. In addition, a biobank allows addressing specific scientific issues on a variety of open questions. The cohort will provide a platform for carrying out scientific research projects on PSC. In addition, the cohort will allow collaborations with reference networks on PSC abroad

Detailed Summary:
Sponsor: Fondazione Epatocentro Ticino

Current Primary Outcome:

• Disease course [ Time Frame: 3 years ]
  Observing disease course
• Disease features [ Time Frame: 3 years ]
  Observing disease features in Swiss population and see if they are similar to other countries'
• Response to treatment [ Time Frame: 3 years ]
• Overall survival [ Time Frame: 3 years ]
• Transplantation-free survival rate [ Time Frame: 3 years ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Fondazione Epatocentro Ticino

Dates:
Date Received: May 8, 2017
Date Started: February 28, 2017
Date Completion: December 31, 2022
Last Updated: May 16, 2017
Last Verified: May 2017